Thumbnail website_Oculus_Thumbnail website Oculus
October 15, 2024

The All-New Pentacam Cornea OCT Offers Synergy for the Future of Corneal Assessment

OCULUS’ latest innovation, the Pentacam® Cornea OCT, made its highly anticipated debut at ESCRS 2024 in Barcelona—and some of the…

Thumbnail (3)
May 24, 2024

APGC 2024 Day 1 Round-up: The Thrilla in Manila is All about Glaucoma! 

Amidst the heat, traffic and dust, all roads lead to Manila (Philippines) this weekend as the world’s brightest minds in…

popular posts
Interventional glaucoma
March 6, 2025

A New Interventional Glaucoma Consensus Protocol Has Arrived. Here’s What You Need to Know

Thumbnail_article___1200x675_RadiusXR,_Glaukos_and_Topcon_Announce_Collaboration_and_the_Launch_of_Inspire
March 13, 2025

RadiusXR, Glaukos and Topcon Announce Collaboration and the Launch of Inspire

latest posts
Thumbnail_article___1200x675_Novel_Bilastine_0.6__Eye_Drop_Promotes_Corneal_Wound_Healing
March 14, 2025

Novel Bilastine 0.6% Eye Drop Supports Hydration and Corneal Wound Healing 

Thumbnail_article___1200x675_RadiusXR,_Glaukos_and_Topcon_Announce_Collaboration_and_the_Launch_of_Inspire
March 13, 2025

RadiusXR, Glaukos and Topcon Announce Collaboration and the Launch of Inspire

Interventional glaucoma
March 6, 2025

A New Interventional Glaucoma Consensus Protocol Has Arrived. Here’s What You Need to Know

Thumbnail article _ 1200x675_FDA approval brings a major upgrade for ANI Pharmaceutical’s Purified Cortrophin Gel
March 5, 2025

ANI Pharmaceuticals Gets FDA Nod for Cortrophin Gel Prefilled Syringe

Thumbnail article _ 1200x675_ ForSight Robotics Achieves ISO 13485 2016 Certification
February 28, 2025

ForSight Robotics Secures ISO 13485:2016 Certification 

Thumbnail article _ 1200x675_ZEISS VISUMAX 800 with SMILE pro software receives approval in China
February 27, 2025

ZEISS VISUMAX 800 with SMILE Pro Software Approved in China 

[Opus Genetics] Announces FDA Fast Track and Enrollment Updates
February 27, 2025

Opus Genetics Announces FDA Fast Track Nod for Night Driving Impairment Drug, Clinical Updates

Newsroom FDA Accepts NDA for Glaukos’ Corneal Cross Linking Drug Treatment
February 25, 2025

FDA Accepts NDA for Glaukos’ Corneal Cross-Linking Drug Treatment

Discover our fascinating content at issuu

explore